Literature DB >> 56590

Reduction of menstrual blood-loss by prostaglandin-synthetase inhibitors.

A B Anderson, P J Haynes, J Guillebaud, A C Turnbull.   

Abstract

Six patients with menorrhagia due to dysfunctional uterine bleeding and one patient with an intrauterine contraceptive device were treated with prostaglandin-synthetase inhibitors in an attempt to reduce their excessive menstrual blood-loss. Mefenamic acid (six patients) or flufenamic acid (one patient) taken during menstruation for 2-3 cycles reduced menstrual loss in each patient. These preliminary observations suggest a new treatment for a common gynaecological problem and could imply that prostaglandins are involved in the aetiology of excessive menstrual blood-loss in such patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 56590     DOI: 10.1016/s0140-6736(76)91612-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  15 in total

1.  Prostaglandin inhibitors: rational therapy for dysmenorrhea.

Authors:  J Sorbie
Journal:  Can Fam Physician       Date:  1982-01       Impact factor: 3.275

2.  Dysfunctional uterine bleeding.

Authors:  R F Casper
Journal:  Can Fam Physician       Date:  1983-04       Impact factor: 3.275

Review 3.  Management of menorrhagia.

Authors:  A L Magos
Journal:  BMJ       Date:  1990-06-16

4.  Menorrhagia.

Authors:  M Rees
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-21

5.  Effect of acetylsalicylic acid, paracetamol, and placebo on pain and blood loss in dysmenorrhoeic women.

Authors:  T Janbu; P Løkken; B I Nesheim
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

Review 6.  Treatment of dysmenorrhoea and premenstrual syndrome with non-steroidal anti-inflammatory drugs.

Authors:  S S Shapiro
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

7.  Haemostatic mechanism in the endometrium: role of cyclo-oxygenase products and coagulation factors.

Authors:  T J Gelety; G Chaudhuri
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

8.  Prostaglandins and menstrual disorders.

Authors:  M G Elder
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-10

9.  The treatment of unexplained menorrhagia.

Authors:  E Cope
Journal:  Ir J Med Sci       Date:  1983-06       Impact factor: 1.568

10.  Danazol in the treatment of menorrhagia.

Authors:  E Cope
Journal:  Drugs       Date:  1980-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.